Warning letter
Frontier Medical Products [ARCHIVED]: warning letter of Sep 1, 2010
FDA warning letter 129630 · Minneapolis District Office
Key facts
| Reference number | 129630 |
|---|---|
| Company | Frontier Medical Products [ARCHIVED] |
| Subject | CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated |
| Issue date | Sep 1, 2010 |
| Posted date | Sep 1, 2010 |
| Issuing office | Minneapolis District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Inspection city | Grafton |
| Inspection ZIP | 53024 |
| Inspection start date | Jun 7, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: